Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA: A promising platform for cancer immunotherapy
Byoungjae Kong, Yelee Kim, Eun Hye Kim, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114993-114993
Open Access | Times Cited: 22

Showing 22 citing articles:

Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
Yelee Kim, Jiwoong Choi, Eun Hye Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 19
mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 39
Stability indicating ion-pair reversed-phase liquid chromatography method for modified mRNA
Jonathan Currie, Jacob. R Dahlberg, Ester Lundberg, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116144-116144
Open Access | Times Cited: 11
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Pei Huang, Hongzhang Deng, Changrong Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 16
Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing
Qiubing Chen, Xuebin Wang, Yizhou Zhang, et al.
National Science Review (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 7
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Nanoparticles for mRNA-based cancer immunotherapy
Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, et al.
Advances in immunology (2025)
Closed Access
Ionizable Lipids with Branched Linkers Enhance the Delivery of mRNA Vaccines
Ji‐Wei Liu, Wenjing Sun, Bing Xiao, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 13552-13564
Closed Access
Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy
Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, et al.
Advances in immunology (2025)
Closed Access
Low-Dose Mildronate-Derived Lipidoids for Efficient mRNA Vaccine Delivery with Minimal Inflammation Side Effects
Ji‐Wei Liu, Bing Xiao, Yong‐Le Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23289-23300
Closed Access | Times Cited: 2
Interaction design in mRNA delivery systems
Mengyao Yu, Lixin Lin, Dezhong Zhou, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 413-426
Closed Access | Times Cited: 2
LNP-mRNA delivers TNF-α antibody to deep cartilage and protects against osteoarthritis
Baixing Li, Lei Cui, Keyu Kong, et al.
Chemical Engineering Journal (2024) Vol. 500, pp. 156723-156723
Closed Access | Times Cited: 1
The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 1
Nanoformula Design for Inducing Non‐Apoptotic Cell Death Regulation: A Powerful Booster for Cancer Immunotherapy
Yi Hu, Qing Yu, Xia Li, et al.
Advanced Healthcare Materials (2024) Vol. 14, Iss. 2
Closed Access | Times Cited: 1
Stability Indicating Ion-Pair Reversed-Phase Liquid Chromatography Method for Modified mRNA
Jonathan Currie, Jacob. R Dahlberg, Ester Lundberg, et al.
(2023)
Open Access | Times Cited: 3
The potential of mRNA vaccine in HCC treatment
Rui Han
International Journal of Immunotherapy and Cancer Research (2023) Vol. 9, Iss. 1, pp. 008-012
Open Access | Times Cited: 2
Better, Faster, Stronger: Accelerating mRNA‐Based Immunotherapies With Nanocarriers
Henrique Carvalho, Tiago A. S. Fidalgo, Rita C. Acúrcio, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
Exosome-mediated ACSL4 mRNA delivery suppresses WSSV infection by promoting ferroptosis in mud crab
Xinshan Zhao, Mingming Sun, Yi Gong
Aquaculture (2024), pp. 742078-742078
Closed Access
Progress in modifying and delivering mRNA therapies for cancer immunotherapy
Karan Goel, Isha Chawla, Garima Garima, et al.
Advances in immunology (2024)
Closed Access
Preface: A new era of RNA-based therapies
Sun Hwa Kim, Kanjiro Miyata
Advanced Drug Delivery Reviews (2023) Vol. 205, pp. 115162-115162
Closed Access | Times Cited: 1
Page 1

Scroll to top